The biopharmaceutical contract manufacturing sector is set to
expand substantially in the next few years as biotech companies
increasingly rely on outsourcing to improve efficiency and reduce
costs, new research suggests.
US life science company Serologicals has entered into a €167.6
million merger with cell signallin specialist Upstate, creating a
significant presence in the preclinical drug screening and target
validation market, the fastest growing...